Jubilant Pharmova Ltd.
Fundamentals
- Market cap
- ₹16,029 cr
- P/E
- 805.47×
- ROE
- 13.42%
- Debt / equity
- 0.39
- Div yield
- 0.50%
- 52-week range
- 786.05 — 1248.00
The timeline — 3 notes on Jubilant Pharmova Ltd.
May 2026
- 22 May 26 · 19:43 IST Brief Brief · Order Wins
Jubilant Pharmova subsidiary lands ₹107.89 cr tax demand
A transfer pricing order for FY23 hits the subsidiary, forcing a ₹37.70 cr write-down of deferred tax assets.
- 22 May 26 · 14:41 IST Brief Brief
Jubilant Pharmova names Ashish Mukkirwar as CFO
Arun Kumar Sharma steps down into an advisory role as the company works through regulatory hurdles at its Montreal facility.
- 22 May 26 · 14:27 IST Brief Brief · Earnings
Jubilant Pharmova profits halved to ₹397 cr as remediation costs weigh
Regulatory challenges at the Montreal site drag on bottom-line performance despite 14.5% revenue growth.